| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.39B | +8.4% |
| Cost of Revenue | $5.24B | -15.0% |
| Gross Profit | $144.0M | +112.0% |
| R&D Expense | $1.67B | +3.4% |
| SG&A Expense | $2.06B | +9.9% |
| Operating Income | -$3.58B | +23.5% |
| Pre-tax Income | -$3.62B | +23.6% |
| Income Tax | $6.0M | +20.0% |
| Net Income | -$3.65B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.58B | -32.4% |
| Short-term Investments | $2.50B | +4.0% |
| Accounts Receivable | $555.0M | +25.3% |
| Inventory | $1.59B | -29.1% |
| Current Assets | $8.59B | -18.8% |
| Total Assets | $14.86B | -3.5% |
| Current Liabilities | $3.69B | +64.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$779.0M | +54.6% |
| Capital Expenditures | $1.71B | +49.9% |
| Investing Cash Flow | -$1.83B | +7.7% |
| Financing Cash Flow | $886.0M | -22.0% |
| Free Cash Flow | -$2.49B | +12.9% |
| +23.2% |
| EPS (Basic) | -$3.07 | +34.5% |
| EPS (Diluted) | -$3.07 | +34.5% |
| Long-term Debt |
| $4.44B |
| -0.0% |
| Total Liabilities | $10.27B | +16.1% |
| Stockholders' Equity | $4.59B | -30.0% |